Distribution of FGFR2, TNRC9, MAP3K1, LSP1, and 8q24 alleles in genetically enriched breast cancer patients versus elderly tumor-free women

Cancer Genetics and Cytogenetics

Volumn 199, Issue 1, 2010, Pages 69-72

  Gorodnova, Tatiana V ^a   Kuligina, Ekatherina Sh ^a   Yanus, Grigory A ^a   Katanugina, Anna S ^a   Abysheva, Svetlana N ^a   Togo, Alexandr V ^a   Imyanitov, Evgeny N ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2; GENE PRODUCT; PROTEIN LSP1; PROTEIN MAP3K1; PROTEIN TNRC9; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; FGFR2 PROTEIN, HUMAN; LSP1 PROTEIN, HUMAN; MAP3K1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; PROGESTERONE RECEPTOR; TNRC9 PROTEIN, HUMAN;

ALLELE; BREAST CANCER; CANCER RESEARCH; CANCER SURVIVAL; CHROMOSOME 8Q; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; LETTER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; AGED; BREAST TUMOR; CASE CONTROL STUDY; CHROMOSOME 8; GENETICS; MIDDLE AGED;

ADULT; AGED; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MAP KINASE KINASE KINASE 1; MICROFILAMENT PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, PROGESTERONE;

EID: 77951897844     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.01.020     Document Type: Letter

References (26)

1. Easton D.F., Pooley K.A., Dunning A.M., Pharoah P.D., Thompson D., Ballinger D.G. SEARCH collaborators. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007, 447:1087-1093.
2. Hunter D.J., Kraft P., Jacobs K.B., Cox D.G., Yeager M., Hankinson S.E., Wacholder S., Wang Z., Welch R., Hutchinson A., Wang J., Yu K., Chatterjee N., Orr N., Willett W.C., Colditz G.A., Ziegler R.G., Berg C.D., Buys S.S., McCarty C.A., Feigelson H.S., Calle E.E., Thun M.J., Hayes R.B., Tucker M., Gerhard D.S., Fraumeni J.F., Hoover R.N., Thomas G., Chanock S.J. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007, 39:870-874.
3. Gold B., Kirchhoff T., Stefanov S., Lautenberger J., Viale A., Garber J., Friedman E., Narod S., Olshen A.B., Gregersen P., Kosarin K., Olsh A., Bergeron J., Ellis N.A., Klein R.J., Clark A.G., Norton L., Dean M., Boyd J., Offit K. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci U S A 2008, 105:4340-4345.
4. Stacey S.N., Manolescu A., Sulem P., Thorlacius S., Gudjonsson S.A., Jonsson G.F., Jakobsdottir M., Bergthorsson J.T., Gudmundsson J., Aben K.K., Strobbe L.J., Swinkels D.W., van Engelenburg K.C., Henderson B.E., Kolonel L.N., Le Marchand L., Millastre E., Andres R., Saez B., Lambea J., Godino J., Polo E., Tres A., Picelli S., Rantala J., Margolin S., Jonsson T., Sigurdsson H., Jonsdottir T., Hrafnkelsson J., Johannsson J., Sveinsson T., Myrdal G., Grimsson H.N., Sveinsdottir S.G., Alexiusdottir K., Saemundsdottir J., Sigurdsson A., Kostic J., Gudmundsson L., Kristjansson K., Masson G., Fackenthal J.D., Adebamowo C., Ogundiran T., Olopade O.I., Haiman C.A., Lindblom A., Mayordomo J.I., Kiemeney L.A., Gulcher J.R., Rafnar T., Thorsteinsdottir U., Johannsson O.T., Kong A., Stefansson K. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2008, 40:703-706.
5. Thomas G., Jacobs K.B., Kraft P., Yeager M., Wacholder S., Cox D.G., Hankinson S.E., Hutchinson A., Wang Z., Yu K., Chatterjee N., Garcia-Closas M., Gonzalez-Bosquet J., Prokunina-Olsson L., Orr N., Willett W.C., Colditz G.A., Ziegler R.G., Berg C.D., Buys S.S., McCarty C.A., Feigelson H.S., Calle E.E., Thun M.J., Diver R., Prentice R., Jackson R., Kooperberg C., Chlebowski R., Lissowska J., Peplonska B., Brinton L.A., Sigurdson A., Doody M., Bhatti P., Alexander B.H., Buring J., Lee I.M., Vatten L.J., Hveem K., Kumle M., Hayes R.B., Tucker M., Gerhard D.S., Fraumeni J.F., Hoover R.N., Chanock S.J., Hunter D.J. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 2009, 41:579-584.
6. Zheng W., Long J., Gao Y.T., Li C., Zheng Y., Xiang Y.B., Wen W., Levy S., Deming S.L., Haines J.L., Gu K., Fair A.M., Cai Q., Lu W., Shu X.O. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 2009, 41:324-328.
7. Stacey S.N., Manolescu A., Sulem P., Rafnar T., Gudmundsson J., Gudjonsson S.A., Masson G., Jakobsdottir M., Thorlacius S., Helgason A., Aben K.K., Strobbe L.J., Albers-Akkers M.T., Swinkels D.W., Henderson B.E., Kolonel L.N., Le Marchand L., Millastre E., Andres R., Godino J., Garcia-Prats M.D., Polo E., Tres A., Mouy M., Saemundsdottir J., Backman V.M., Gudmundsson L., Kristjansson K., Bergthorsson J.T., Kostic J., Frigge M.L., Geller F., Gudbjartsson D., Sigurdsson H., Jonsdottir T., Hrafnkelsson J., Johannsson J., Sveinsson T., Myrdal G., Grimsson H.N., Jonsson T., von Holst S., Werelius B., Margolin S., Lindblom A., Mayordomo J.I., Haiman C.A., Kiemeney L.A., Johannsson O.T., Gulcher J.R., Thorsteinsdottir U., Kong A., Stefansson K. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2007, 39:865-869.
8. Ahmed S., Thomas G., Ghoussaini M., Healey C.S., Humphreys M.K., Platte R., Morrison J., Maranian M., Pooley K.A., Luben R., Eccles D., Evans D.G., Fletcher O., Johnson N., dos Santos Silva I., Peto J., Stratton M.R., Rahman N., Jacobs K., Prentice R., Anderson G.L., Rajkovic A., Curb J.D., Ziegler R.G., Berg C.D., Buys S.S., McCarty C.A., Feigelson H.S., Calle E.E., Thun M.J., Diver W.R., Bojesen S., Nordestgaard B.G., Flyger H., Dörk T., Schürmann P., Hillemanns P., Karstens J.H., Bogdanova N.V., Antonenkova N.N., Zalutsky I.V., Bermisheva M., Fedorova S., Khusnutdinova E., SEARCH, Kang D., Yoo K.Y., Noh D.Y., Ahn S.H., Devilee P., van Asperen C.J., Tollenaar R.A., Seynaeve C., Garcia-Closas M., Lissowska J., Brinton L., Peplonska B., Nevanlinna H., Heikkinen T., Aittomäki K., Blomqvist C., Hopper J.L., Southey M.C., Smith L., Spurdle A.B., Schmidt M.K., Broeks A., van Hien R.R., Cornelissen S., Milne R.L., Ribas G., González-Neira A., Benitez J., Schmutzler R.K., Burwinkel B., Bartram C.R., Meindl A., Brauch H., Justenhoven C., Hamann U., GENICA Consortium, Chang-Claude J., Hein R., Wang-Gohrke S., Lindblom A., Margolin S., Mannermaa A., Kosma V.M., Kataja V., Olson J.E., Wang X., Fredericksen Z., Giles G.G., Severi G., Baglietto L., English D.R., Hankinson S.E., Cox D.G., Kraft P., Vatten L.J., Hveem K., Kumle M., Sigurdson A., Doody M., Bhatti P., Alexander B.H., Hooning M.J., van den Ouweland A.M., Oldenburg R.A., Schutte M., Hall P., Czene K., Liu J., Li Y., Cox A., Elliott G., Brock I., Reed M.W., Shen C.Y., Yu J.C., Hsu G.C., Chen S.T., Anton-Culver H., Ziogas A., Andrulis I.L., Knight J.A., Beesley J., Goode E.L., Couch F., Chenevix-Trench G., Hoover R.N., Ponder B.A., Hunter D.J., Pharoah P.D., Dunning A.M., Chanock S.J., Easton D.F. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 2009, 41:585-590. kConFab; Australian Ovarian Cancer Study Group.
9. Antoniou A.C., Spurdle A.B., Sinilnikova O.M., Healey S., Pooley K.A., Schmutzler R.K., Versmold B., Engel C., Meindl A., Arnold N., Hofmann W., Sutter C., Niederacher D., Deissler H., Caldes T., Kämpjärvi K., Nevanlinna H., Simard J., Beesley J., Chen X., Neuhausen S.L., Rebbeck T.R., Wagner T., Lynch H.T., Isaacs C., Weitzel J., Ganz P.A., Daly M.B., Tomlinson G., Olopade O.I., Blum J.L., Couch F.J., Peterlongo P., Manoukian S., Barile M., Radice P., Szabo C.I., Pereira L.H., Greene M.H., Rennert G., Lejbkowicz F., Barnett-Griness O., Andrulis I.L., Ozcelik H., OCGN, Gerdes A.M., Caligo M.A., Laitman Y., Kaufman B., Milgrom R., Friedman E., Domchek S.M., Nathanson K.L., Osorio A., Llort G., Milne R.L., Benítez J., Hamann U., Hogervorst F.B., Manders P., Ligtenberg M.J., van den Ouweland A.M., Peock S., Cook M., Platte R., Evans D.G., Eeles R., Pichert G., Chu C., Eccles D., Davidson R., Douglas F., EMBRACE, Godwin A.K., Barjhoux L., Mazoyer S., Sobol H., Bourdon V., Eisinger F., Chompret A., Capoulade C., Bressac-de Paillerets B., Lenoir G.M., Gauthier-Villars M., Houdayer C., Stoppa-Lyonnet D., GEMO, Chenevix-Trench G., Easton D.F., CIMBA Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 2008, 82:937-948. Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Swedish BRCA1 and BRCA2 study collaboratorsSwedish BRCA1 and BRCA2 study collaborators, DNA-HEBON collaboratorsDNA-HEBON collaborators.
10. Hemminki K, Müller-Myhsok B, Lichtner P, Engel C, Chen B, Burwinkel B, Försti A, Sutter C, Wappenschmidt B, Hellebrand H, Illig T, Arnold N, Niederacher D, Dworniczak B, Deissler H, Kast K, Gadzicki D, Meitinger T, Wichmann HE, Kiechle M, Bartram CR, Schmutzler RK, Meindl A. Low risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients. Int J Cancer (in press).
11. Latif A., Hadfield K.D., Roberts S.A., Shenton A., Lalloo F., Black G.C., Howell A., Evans D.G., Newman W.G. Breast cancer susceptibility variants alter risks in familial disease. J Med Genet 2010, 47:126-231.
12. Rebbeck T.R., DeMichele A., Tran T.V., Panossian S., Bunin G.R., Troxel A.B., Strom B.L. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. Carcinogenesis 2009, 30:269-274.
13. Antoniou A.C., Sinilnikova O.M., McGuffog L., Healey S., Nevanlinna H., Heikkinen T. The Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, EMBRACE, GEMO, Breast Cancer Family Registry, Georgia Chenevix-Trench, on behalf of CIMBA. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 2009, 18:4442-4456.
14. Fletcher O., Johnson N., Gibson L., Coupland B., Fraser A., Leonard A., dos Santos Silva I., Ashworth A., Houlston R., Peto J. Association of genetic variants at 8q24 with breast cancer risk. Cancer Epidemiol Biomarkers Prev 2008, 17:702-705.
15. Mcinerney N., Colleran G., Rowan A., Walther A., Barclay E., Spain S., Jones A.M., Tuohy S., Curran C., Miller N., Kerin M., Tomlinson I., Sawyer E. Low penetrance breast cancer predisposition SNPs are site specific. Breast Cancer Res Treat 2009, 117:151-159.
16. Milne R.L., Benítez J., Nevanlinna H., Heikkinen T., Aittomäki K., Blomqvist C. The ConFab Investigators, AOCS Group, Breast Cancer Association Consortium. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. J Natl Cancer Inst 2009, 101:1012-1018.
17. Zheng W., Cai Q., Signorello L.B., Long J., Hargreaves M.K., Deming S.L., Li G., Li C., Cui Y., Blot W.J. Evaluation of 11 breast cancer susceptibility loci in African-American women. Cancer Epidemiol Biomarkers Prev 2009, 18:2761-2764.
18. Kirchhoff T., Chen Z.Q., Gold B., Pal P., Gaudet M.M., Kosarin K., Levine D.A., Gregersen P., Spencer S., Harlan M., Robson M., Klein R.J., Hudis C.A., Norton L., Dean M., Offit K. The 6q22.33 locus and breast cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2009, 18:2468-2475.
19. Easton D.F., Eeles R.A. Genome-wide association studies in cancer. Hum Mol Genet 2008, 17:R109-R115.
20. Antoniou A.C., Easton D.F. Polygenic inheritance of breast cancer: Implications for design of association studies. Genet Epidemiol 2003, 25:190-202.
21. Imyanitov E.N., Hanson K.P. Molecular pathogenesis of bilateral breast cancer. Cancer Lett 2003, 191:1-7.
22. Imyanitov E.N., Cornelisse C.J., Devilee P. Searching for susceptibility alleles: emphasis on bilateral breast cancer. Int J Cancer 2007, 121:921-923.
23. Kuligina ESh, Reiner A, Imyanitov EN, Begg CB. Evaluating cancer epidemiologic risk factors using multiple primary malignancies. Am J Epidemiol (in press).
24. Imyanitov E.N. Use of elderly tumor-free subjects as a " supercontrol" for cancer epidemiological studies: pros and cons. Mech Ageing Dev 2009, 130:122-127.
25. Sokolenko A.P., Rozanov M.E., Mitiushkina N.V., Sherina N.Y., Iyevleva A.G., Chekmariova E.V., Buslov K.G., Shilov E.S., Togo A.V., Bit-Sava E.M., Voskresenskiy D.A., Chagunava O.L., Devilee P., Cornelisse C., Semiglazov V.F., Imyanitov E.N. Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia. Fam Cancer 2007, 6:281-286.
26. Pharoah P.D., Antoniou A.C., Easton D.F., Ponder B.A. Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 2008, 358:2796-2803.